Page 1164 - Basic _ Clinical Pharmacology ( PDFDrive )
P. 1164

1150     SECTION X  Special Topics


                 long-acting form is to be used; may fail to specify a strength or   interactions are listed in Chapter 66 of this book as well as in
                 notation for long-acting forms; or may authorize “as needed”   package inserts.
                 (prn) use that fails to state what conditions will justify the need.  Physicochemical incompatibilities are of particular concern
                                                                     when parenteral administration is planned. For example, certain
                 POOR PRESCRIPTION WRITING                           insulin preparations should not be mixed. Similarly, the simultane-
                                                                     ous administration of antacids or products high in metal content
                                                                     may compromise the absorption of many drugs in the intestine,
                 Poor  prescription  writing  is  traditionally  exemplified  by  illegible   eg, tetracyclines. The package insert and the Handbook on Inject-
                 handwriting. However, other types of poor writing are common and   able Drugs (see References) are good sources for this information.
                 often more dangerous. One of the most important is the misplaced
                 or ambiguous decimal point. Thus “.1” is easily misread as “1,” a
                 tenfold overdose, if the  decimal point is  not  unmistakably  clear.   E-PRESCRIBING
                 This danger is easily avoided by always preceding the decimal point
                 with a zero. On the other hand, appending an unnecessary zero   Seventy percent of prescriptions in the USA are now E-prescribed.
                 after a decimal point increases the risk of a tenfold overdose, because   Congress has passed legislation related to E-prescribing, including
                 “1.0 mg” is easily misread as “10 mg,” whereas “1 mg” is not. The   Medicare Improvement for Patients and Providers Act (MIPPA)
                 slash or virgule (“/”) was traditionally used as a substitute for a deci-  and the Medicare and Medicaid Electronic Health Record Incen-
                 mal point. This should be abandoned because it is too easily misread   tive Program or the “meaningful use program.” E-prescribing
                 as the numeral “1.” Similarly, the abbreviation “U” for units should   provides an electronic flow of information between the prescriber,
                 never be used because “10 U” is easily misread as “100”; the word   intermediary, pharmacy, and health plan.  The health plan can
                 “units” should always be written out. Doses in micrograms should   provide information on patient eligibility, formulary, benefits,
                 always have this unit written out because the abbreviated form   costs, and sometimes, a medication history. The prescriber selects
                 (“μg”) is very easily misread as “mg,” a 1000-fold overdose! Orders   the medication, strength, dosage form, quantity, and directions
                 for drugs specifying only the number of dosage units and not the   for use and the prescription is transmitted to the pharmacy
                 total dose required should not be filled if more than one size dosage   where the appropriate data fields are populated. The pharmacist
                 unit exists for that drug. For example, ordering “one ampule of furo-  reviews the order and, if appropriate, dispenses the prescription.
                 semide” is unacceptable because furosemide is available in ampules   The electronic system must be Health Insurance Portability and
                 that contain 20, 40, or 100 mg of the drug. The abbreviation “OD”   Accountability Act  (HIPAA)-compliant, and there is often a
                 should be used (if at all) only to mean “the right eye”; it has been   business association agreement between the parties involved.
                 used for “every day” and has caused inappropriate administration   Prescribers can obtain decision support information such as
                 of drugs into the eye. Similarly, “Q.D.” or “QD” should not be   disease-drug and drug-drug interaction information or cost infor-
                 used because it is often read as “QID,” resulting in four daily doses   mation prior to prescribing as part of the health plan information.
                 instead of one. Acronyms and abbreviations such as “ASA” (aspirin),   Prescriptions can be clear in their writing, but pull-down drug lists
                 “5-ASA” (5-aminosalicylic acid), “6MP” (6-mercaptopurine), etc,   can create new errors. Prescription renewals can be processed elec-
                 should not be used; drug names should be written out. Unclear   tronically and drug misuse or abuse may be identifiable. Theoretically,
                 handwriting can be lethal when drugs with similar names but very   time to process prescription orders should be reduced and patients
                 different effects are available, eg, acetazolamide and acetohexamide,   would have their medication ready when they arrive at the pharmacy.
                 methotrexate and metolazone. In this situation, errors are best   The DEA has issued rules for e-prescribing of controlled
                 avoided by noting the indication for the drug in the body of the   substances. Currently, only registered prescribers can e-prescribe,
                 prescription, eg, “acetazolamide, for glaucoma.” Pharmacy and     and  there  will  be  several  independent  identification  proofing
                 Therapeutics committees have developed some additional princi-  sources required: a unique pin number, or retinal scan, or a finger
                 ples to lessen errors, such as a High-Alert Medication list and using   print.  The objective is to prevent drug diversion. DEA regis-
                 a comma (in the USA) when the dose exceeds 999.     trants, including pharmacies and physicians, can order controlled
                                                                     drugs via computer using a specific form once they are certified
                 INAPPROPRIATE DRUG PRESCRIPTIONS                    (Controlled Substances Ordering System, CSOS).

                 Prescribing an inappropriate drug for a particular patient often
                 results  from  failure  to  recognize  contraindications  imposed  by   COMPLIANCE
                 other diseases the patient may have, failure to obtain informa-
                 tion about other drugs the patient is taking (including over-the-  Compliance (also called adherence) is the extent to which
                 counter drugs), or failure to recognize possible physicochemical   patients follow treatment instructions.  There are four types
                 incompatibilities between drugs that may react with each other.   of noncompliance leading to medication errors and increased
                 Contraindications to drugs in the presence of other diseases or   health care costs as given below:
                 pharmacokinetic characteristics are listed in the discussions of the   1. The patient fails to obtain the medication. Some studies sug-
                 drugs described in this book. The manufacturer’s package insert   gest that one third of patients never have their prescriptions
                 usually contains similar information. Many of the important drug   filled. Patients usually leave the hospital without obtaining
   1159   1160   1161   1162   1163   1164   1165   1166   1167   1168   1169